Skip subpage navigation
Influenza is a highly contagious viral infection. There are three main antigen types of influenza: types A, B, and C. Influenza type A causes moderate to severe illness and affects all age groups. Type A can infect both humans and animals. The notion that influenza type B generally causes milder disease than type A has been recently challenged and is more fatal in children. Type B mainly infects humans. Influenza type C only causes mild respiratory illness. Influenza activity peaks from December to March in the Northern Hemisphere.
Influenza is transmitted from person to person mainly when an infected person coughs or sneezes. Transmission can also occur from direct contact with respiratory secretions, such as when touching surfaces contaminated with influenza virus and then touching the eyes, nose, or mouth, or from indirect contact with droplets from coughs or sneezes. Transmission can occur from the day before symptoms begin until about 5 days after symptoms begin in adults, or up to 10 days or more after symptoms begin in children.
About 50% of infected persons will develop "classic" influenza disease. This is characterized by the abrupt onset of fever, muscle pain, sore throat, nonproductive cough, runny nose, and headache. These symptoms generally last from 2 to 3 days. However, some people may experience a loss of strength or energy for several weeks. In addition, some people may develop complications, such as pneumonia.
Source: Centers for Disease Control and Prevention
You also may be interested in...
Publication
Sep 7, 2023
.PDF |
755.45 KB
The purpose of this standing order is to reduce morbidity and mortality from influenza by vaccinating children and adolescents who meet the criteria established by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) and the Department of Defense (DOD).
Publication
May 12, 2020
.PDF |
326.91 KB
A checklist of suggested supplies for an off-site influenza clinic.
Publication
May 12, 2020
.PDF |
166.19 KB
A pre-designed reminder card for parents whose children are being immunized against influenza for the first time, thus requiring two doses of vaccine separated by at least 28 days.
Publication
Apr 21, 2017
When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available.
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: July 11, 2024